Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Gastroenterology. 2022 Aug 2;163(6):1510–1521.e6. doi: 10.1053/j.gastro.2022.07.071

Figure 3.

Figure 3.

(A) Mean gluten immunogenic peptide (GIP) concentration in urine before (V3), during (6 weekly readings) and after (V4) the GC treatment period with unpaired, 2-tailed, t-test p-value. (B) Subject responses for GIP concentration in urine showing individual subject changes. (C) Box and whisker plot showing min and max, 1st and 3rd quartile and median and ANCOVA p-value.